From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

Presentation Title: Comparing experiences at interstitial lung disease (ILD) centers and community practices (CP) from the perspective of people with idiopathic pulmonary fibrosis (IPF) Session: Oral ...

In a report released on September 27, Faisal Khurshid from Leerink Partners reiterated a Buy rating on PureTech Health (PRTC – Research ...

Only the top-spec Shine trim gets automatic gearbox variant with prices starting from Rs 10 lakh (Ex-sh). Buyers can also ...

PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...

New Citroen Aircross SUV has come with several improvements to enhance its safety, comfort and overall driving experience.

The Peugeot 408 was launched in Malaysia back in April this year and is available in three locally-assembled (CKD) variants, ...

If you squint a bit (okay, quite hard), the Citroen C3 Aircross is the brand’s modern equivalent to the classic 2CV. It’s an ...

The C3 Automatic is powered by the same Puretech 110, 1.2-litre, 3-cylinder, turbo petrol engine which puts out 110 PS of ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) has achieved a significant milestone with the FDA's recent approval of Cobenfy ...

Bristol-Myers Squibb (BMY) shares rose early Friday as the biopharmaceutical company obtained approval from the US Food and Drug Administration for its Cobenfy drug to treat schizophrenia in adults.

PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia. The Boston, Massachusetts-based biotechnology company said the milestone ...